• PDF / 807,750 Bytes
• 4 Pages / 595.276 x 790.866 pts Page_size
• 70 Downloads / 219 Views

DOWNLOAD

REPORT

CASE REPORT

Prostate‑specific antigen (PSA) bounce following salvage radiotherapy to the prostate bed in a patient with prostate cancer post‑prostatectomy Michael Rowe1 · Ellis Adamson1 · John McGrane1 Received: 6 May 2020 / Accepted: 18 June 2020 © The Japan Society of Clinical Oncology 2020

Abstract We present a case of prostate-specific antigen (PSA) bounce in a 76 year old man who underwent salvage radiotherapy to the prostate bed following biochemical relapse 6 years post-radical prostatectomy for a T2N0 Gleason grade 3 + 3 prostate adenocarcinoma; 10 months following completion of salvage radiotherapy for biochemical PSA recurrence of 0.2 μg/L. Following undetectable results (

Recommend Documents

Prostate-Specific Antigen (PSA)

178 104 35MB

Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory an

153 28 328KB

Salvage Cryotherapy in Prostate Cancer

150 36 5MB

Radiotherapy for Prostate Cancer

199 8 7MB

Salvage Therapy for Prostate Cancer

174 27 5MB

Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiothe

141 28 832KB

Erectile Dysfunction in Salvage Prostate Cancer Therapies

169 3 5MB

Salvage Re-Irradiation After Locoregional Failure with Primary Radiotherapy for Prostate Cancer

155 60 5MB

Contribution of Genetic Variation rs266882 to Prostate-Specific Antigen Levels in Healthy Controls with Serum PSA Below

132 70 195KB

Salvage Prostatectomy for Radio-Recurrent Prostate Cancer

175 25 5MB

The Role of PET in Salvage Therapy for Prostate Cancer

197 81 5MB

Classifying the Reasons Men Consider to be Important in Prostate-Specific Antigen (PSA) Testing Decisions: Evaluating Ri

128 43 264KB